Laboratoire OBO, France – 28 June 2021
1st CE-IVD marked SARS-CoV-2 detection test for Laboratoire OBO following its validation by the CNR.
In its commitment to fight the COVID-19 pandemic, Laboratoire OBO was able to produce its first RT-qPCR test in record time. The CE-marked OSANTYS SARS-CoV-2 RT-qPCR test kit can be applied to three types of
specimens : nasopharyngeal and oropharyngeal swabs and saliva samples. The test detects the presence of the virus directly (without extraction) on nasopharyngeal and oropharyngeal samples, while maintaining very high sensitivity, as shown by the CNR validation.